AstraZeneca PLC (AZN)
63.20
-0.60
(-0.94%)
USD |
NASDAQ |
Nov 20, 16:00
63.71
+0.51
(+0.81%)
Pre-Market: 08:45
AstraZeneca Market Cap: 195.96B for Nov. 20, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 195.96B |
| November 19, 2024 | 197.82B |
| November 18, 2024 | 196.55B |
| November 15, 2024 | 196.05B |
| November 14, 2024 | 201.66B |
| November 13, 2024 | 202.44B |
| November 12, 2024 | 202.13B |
| November 11, 2024 | 200.89B |
| November 08, 2024 | 199.96B |
| November 07, 2024 | 200.58B |
| November 06, 2024 | 197.97B |
| November 05, 2024 | 205.48B |
| November 04, 2024 | 221.48B |
| November 01, 2024 | 221.45B |
| October 31, 2024 | 220.61B |
| October 30, 2024 | 225.82B |
| October 29, 2024 | 233.23B |
| October 28, 2024 | 235.68B |
| October 25, 2024 | 232.70B |
| October 24, 2024 | 235.33B |
| October 23, 2024 | 238.59B |
| October 22, 2024 | 239.74B |
| October 21, 2024 | 240.11B |
| October 18, 2024 | 242.65B |
| October 17, 2024 | 241.91B |
| Date | Value |
|---|---|
| October 16, 2024 | 242.81B |
| October 15, 2024 | 241.38B |
| October 14, 2024 | 242.16B |
| October 11, 2024 | 239.83B |
| October 10, 2024 | 238.34B |
| October 09, 2024 | 240.31B |
| October 08, 2024 | 238.34B |
| October 07, 2024 | 238.34B |
| October 04, 2024 | 240.20B |
| October 03, 2024 | 241.63B |
| October 02, 2024 | 246.74B |
| October 01, 2024 | 243.92B |
| September 30, 2024 | 241.57B |
| September 27, 2024 | 240.67B |
| September 26, 2024 | 242.40B |
| September 25, 2024 | 240.42B |
| September 24, 2024 | 238.34B |
| September 23, 2024 | 239.18B |
| September 20, 2024 | 243.02B |
| September 19, 2024 | 244.64B |
| September 18, 2024 | 243.64B |
| September 17, 2024 | 243.49B |
| September 16, 2024 | 245.07B |
| September 13, 2024 | 242.68B |
| September 12, 2024 | 244.82B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
99.18B
Minimum
Mar 16 2020
271.67B
Maximum
Aug 30 2024
183.99B
Average
191.67B
Median
Market Cap Benchmarks
| GSK PLC | 68.04B |
| Amgen Inc | 154.74B |
| Johnson & Johnson | 368.63B |
| Sanofi SA | 119.79B |
| Moderna Inc | 14.22B |
Market Cap Related Metrics
| PE Ratio | 30.31 |
| PS Ratio | 3.857 |
| PEG Ratio | 3.023 |
| Price to Book Value | 4.812 |
| Price to Free Cash Flow | 29.23 |
| Price | 63.20 |
| Earnings Yield | 3.30% |
| PEGY Ratio | 2.449 |
| Operating PE Ratio | 18.36 |
| Normalized PE Ratio | 25.52 |